אקמול פוקוס ישראל - עברית - Ministry of Health

אקמול פוקוס

teva pharmaceutical indust.ltd - acetylsalicylic acid 250 mg; caffeine 65 mg - caplets - paracetamol - for temporary relief of the pain of headache, mild to moderate pain associated with migraine headache, pain of menstrual descomfort and pain accompanied by fever.

אקמול פוקוס ישראל - עברית - Ministry of Health

אקמול פוקוס

teva pharmaceutical indust.ltd - acetylsalicylic acid 250 mg; caffeine anhydrous 65 mg - caplets - paracetamol - for temporary relief of the pain of headache, mild to moderate pain associated with migraine headache, pain of menstrual descomfort and pain accompanied by fever.

גנדול אבקה מסיסה וטרינרי ישראל - עברית - Ministry of Health

גנדול אבקה מסיסה וטרינרי

romat ltd - acetylsalicylic acid 60 %w/w - powder for solution - to be used in calves, swines. as an anti-inflammatory and analgesic agent in the course of diseases of the locomotorm system, arthritis, neurities, myositis, myalgia. as an anti-inflammatory and antipyretic symptomatic agent and adjuvant in antibiotic chemotherapeutic therapy of anti-febrile bacterial diseases principally of the level of the respiratory and locomotorm systems. as adjuvant in antibiotic therapy in infective diseases in chickens.

אייבו % 2 לילדים ישראל - עברית - Ministry of Health

אייבו % 2 לילדים

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 20 mg/ml - ibuprofen

נבנק ישראל - עברית - Ministry of Health

נבנק

novartis israel ltd - nepafenac - תרחיף לעין - nepafenac 0.1 % - nepafenac - nepafenac - prevention and treatment of postoperative pain and inflammation associated with cataract surgery and reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

סוויס רליף ספרי ג'ל ישראל - עברית - Ministry of Health

סוויס רליף ספרי ג'ל

padagis israel agencies ltd, israel - diclofenac sodium - תמיסה - diclofenac sodium 4 %w/w - diclofenac - diclofenac - for the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures.

פלויקס 75 מג ישראל - עברית - Ministry of Health

פלויקס 75 מג

sanofi israel ltd - clopidogrel as hydrogen sulfate - טבליות מצופות פילם - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

פלויקס 300 מ"ג ישראל - עברית - Ministry of Health

פלויקס 300 מ"ג

sanofi - aventis israel ltd - clopidogrel as hydrogen sulfate 300 mg - film coated tablets - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

קלופיד 75 מ"ג ישראל - עברית - Ministry of Health

קלופיד 75 מ"ג

taro international ltd - clopidogrel 75 mg - film coated tablets - clopidogrel - clopidogrel is indicated in adults for the prevention of atherothrombotic events as follows:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent replacement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy

קלופיד 75 מ"ג ישראל - עברית - Ministry of Health

קלופיד 75 מ"ג

taro international ltd - clopidogrel 75 mg - film coated tablets - clopidogrel - clopidogrel is indicated in adults for the prevention of atherothrombotic events as follows:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent replacement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy